They found that the levels of hepatocyte growth factor (HGF), fibroblast growth factors (FGFs)-2 and −13, and type 1 insulin-like growth factor (IGF-1) were significantly lower in AD patients than in controls. The gene discussed is HGF; the disease is Alzheimer disease.